SEL1L deficiency impairs growth and differentiation of pancreatic epithelial cells

Shuai Li1, Adam B Francisco, Robert J Munroe

  • 1Department of Animal Science, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY 14850, USA.

BMC Developmental Biology
|February 23, 2010
PubMed
Abstract

Insights

Suppressor enhancer lin-12/Notch 1 like (Sel1l) is crucial for pancreatic development. Loss of Sel1l in mice impairs pancreatic cell differentiation and growth, highlighting its role in embryonic organogenesis.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Genetics

Background:

  • The vertebrate pancreas develops from multipotent progenitors.
  • Understanding pancreatic organogenesis is key for diabetes mellitus cell therapies.
  • The role of Suppressor enhancer lin-12/Notch 1 like (Sel1l) in pancreatic development is unknown.

Purpose of the Study:

  • To investigate the function of Sel1l during mouse pancreatic development.
  • To characterize the pancreatic phenotype of Sel1l-deficient mice.

Main Methods:

  • Gene trap mutation in Sel1l.
  • Phenotypic analysis of Sel1l mutant mouse embryos.
  • Pharmacological inhibition of Notch signaling.

Main Results:

  • Sel1l is expressed during pancreatic endocrine and exocrine lineage differentiation.
  • Sel1l homozygous mutant mice exhibit prenatal lethality.
  • Mutant embryos show impaired pancreatic epithelial morphology and cell differentiation, with cells arrested in the progenitor state.
  • Notch signaling inhibition partially rescues the Sel1l mutant phenotype.

Conclusions:

  • Sel1l is essential for the growth and differentiation of pancreatic epithelial cells.
  • Sel1l plays a critical role in mouse embryonic pancreatic development.

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...